Octo

Octo Biotechnology is a molecular diagnostics company focused on multiplex real-time PCR kits for clinical and research laboratories. The company develops CE-IVD-ready assays for inherited and clinically relevant genetic variants, with an emphasis on fast, accurate, and workflow-compatible testing across common real-time PCR instruments. Its portfolio includes thrombophilia, familial Mediterranean fever, HLA-B27, SMN1 screening, and fetal sex determination assays. Octo Biotechnology also offers enabling software and assay-analysis technology, including Octo Clario and its melt-curve analysis protocol, to support genotype interpretation and laboratory workflow efficiency. Overall, the business appears to operate as a commercial diagnostics-tools company rather than a therapeutic drug developer.